<PAGE>

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                              Form 10-KSB/A No. 1

[X]       ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
                             EXCHANGE ACT OF 1934

                  For the fiscal year ended December 31, 2001
                                            -----------------

                        Commission File Number: 1-16119
                                                -------

                           SFBC International, Inc.
                           ------------------------
       (Exact name of small business issuer as specified in its charter)

<TABLE>
<S>                                           <C>
              Delaware                                59-2407464
              --------                                ----------
   (State or other jurisdiction of        (IRS Employer Identification No.)
    incorporation or organization)
</TABLE>

                     11190 Biscayne Blvd., Miami, FL 33181
                     -------------------------------------
              (Address of principal executive offices) (Zip code)

                                (305) 895-0304
                                --------------
                          (Issuer's telephone number)

        Securities registered under Section 12(b) of the Exchange Act:

                                     None

      Securities Registered Pursuant to Section 12(g) of the Exchange Act

                                 Common Stock
                                 ------------
                               (Title of Class)


Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. [X] Yes [_] No
<PAGE>

Indicate by check mark if disclosure of delinquent filers in response to Item
405 of Regulation S-B is not contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB. [X]

State issuer's revenues for its most recent fiscal year.   $31,470,528
                                                           -----------

State the aggregate market value of the voting and non-voting common equity held
by non-affiliates computed by reference to the price at which the common equity
was sold, or the average bid and asked price of such common equity, as of a
specified date within the past 60 days. (See definition of affiliate in Rule
12b-2 of the Exchange Act.) $43,402,692 as of March 26, 2002 computed using the
average bid and asked price of the common stock of the Company, par value $.001
per share, as listed on the National Market System of the Nasdaq Stock Market on
the aforementioned date.

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date. 6,858,042 shares of common stock were
outstanding as of March 26, 2002.

                      DOCUMENTS INCORPORATED BY REFERENCE


The Registrant's proxy statement for the annual meeting of stockholders to be
held on June 24,  2002 is incorporated by reference into Part III of this
Report.

                                      -2-
<PAGE>

     The purpose of this Amendment No.1 is to add electronic copies of certain
portions of schedules to Exhibit 10.13 previously filed in paper pursuant to a
temporary hardship exemption, and to refile complete and legible electronic
copies of a portion of Schedule 4.12 to Exhibit 10.13 previously filed in
electronic format, but of poor quality and in part illegible.

<PAGE>

Item 13. Exhibits and Reports on Form 8-K.

(a)  EXHIBIT INDEX


Exhibit
Number    Description
--------  ---------------------------------------------------------------------
2.1       Agreement and Plan of Merger (SFBC Analytical Laboratories, Inc.)/(6)/
3.1       Certificate of Incorporation /(1)/
3.2       First Amendment to Certificate of Incorporation /(1)/
3.3       Certificate of Correction to Certificate of Incorporation /(2)/
3.4       Bylaws /(1)/
3.5       First Amendment to the Bylaws /(2)/
4.1       Form of Common Stock Certificate /(1)/
10.1      Employment Agreement of Arnold Hantman /(4)/
10.2      Employment Agreement of Lisa Krinsky, M.D. /(4)/
10.3      Employment Agreement of Dr. Gregory Holmes /(1)/
10.4      Employment Agreement of D. Scott Davis /(4)/
10.5      Employment Agreement of Dr. Barrie Phillips /(5)/
10.6      Employment Agreement of David Natan (3)
10.7      Form of Employment Agreement of Marc Lebel (3)
10.8      Form of Employment Agreement of Allan Xu(7)
10.9      Form of Employment Agreement of Ray Carr (3)
10.10     Form of Employment Agreement and Addendum thereto of Thomas Pillsworth
          (3)
10.11     Second Amended and Restated 1999 Stock Option Plan(3)
10.12     Asset Purchase Agreement (SFBC Charlotte, Inc.)* (2)
10.13     Share Purchase Agreement (Anapharm)** (3) CE
10.14     Audit Committee Charter (2)
21        Subsidiaries (3)
23.1      Consent of Grant Thornton LLP (3)
23.2      Consent of Kaufman, Rossin & Co (3)

----------------
*   Confidential Portions have been omitted and filed separately under an
application for Confidential Treatment.
**  Confidential Portions of the Schedules have been omitted and filed
separately under an application for Confidential Treatment.
CE  Electronic copies of certain Schedules to this Exhibit previously filed in
paper pursuant to a temporary hardship exemption are being filed in this Form
10-KSB/A No.1.

(1) Contained in Form SB-2 filed on August 17, 1999
(2) Contained in Form SB-2 filed on October 5, 2000
(3) Contained in Form 10-KSB filed on April 1, 2002
(4) Contained in Form SB-2 filed on July 21, 2000
(5) Contained in Form 10-KSB filed April 13, 2001
(6) Contained in Form 8-K/A filed on August 29, 2001
(7) Contained in Exhibit C to the Agreement and Plan of Merger (SFBC Analytical
Laboratories, Inc.) which is Exhibit 2.1 to this Form 10-KSB.

(b) One Report on Form 8-K was filed during the last quarter of the period
covered by this Report.  That Report, filed on November 16, 2001, disclosed that
we selected Grant Thornton LLP to replace Kauffman, Rossin & Co. as our
independent auditors.

<PAGE>

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized this 10th day of April, 2002.

                                    SFBC International, Inc.


                                    By: /s/ Lisa Krinsky, M.D.
                                        ----------------------------
                                        Lisa Krinsky M.D., President
<PAGE>

                                 EXHIBIT INDEX

The following Schedules are contained in Exhibit 10.13 to the Form 10-KSB filed
on April 1, 2002 and found at pages 20 and 21 of Exhibit 10.13.

The schedules to this Exhibit 10.13 as listed below, are an integral part of
the Agreement that is Exhibit 10.13:

                 Schedule               Description
                 --------               -----------
                 *   Schedule 1.1(a)    Form of Escrow Agreement CE
                 *   Schedule 3.2       Purchase Price and Escrow Allocation CE
                 *   Schedule 3.7       Allocation of Purchase Price CE
                 Schedule 4.12          Financial Statements**
                 *   Schedule 4.19      Material Suppliers and Customers CE
                 Schedule 4.27          Intellectual Property CE
                 *   Schedule 4.28      Equipment Contracts CE
                 *   Schedule 4.33      Employment Matters CE
                 *   Schedule 4.37      Insurance CE
                 *   Schedule 4.38      Material Contracts CE

*   Confidential Treatment Requested for Portions of these Schedules.

CE  Electronic copy of certain Schedules to Exhibit 10.13 previously filed in
    paper pursuant to a temporary hardship exemption.

**  Portion of Schedule refiled due to initial illegibility.
<PAGE>

                  Schedule 4.40            Litigation CE
                  Schedule 4.41            Tax Matters CE
                  *   Schedule 4.42        Tax Data CE
                  *   Schedule 4.46        Trade Allowances CE

*  Confidential Treatment Requested for Portions of these Schedules.

CE Electronic copy of certain Schedules to Exhibit 10.13 previously filed in
   paper pursuant to a temporary hardship exemption.
<PAGE>

                  Schedule 4.40            Litigation CE
                  Schedule 4.41            Tax Matters CE
                  *   Schedule 4.42        Tax Data CE
                  *   Schedule 4.46        Trade Allowances CE
                  Schedule 4.47            Third Party Consents
                  Schedule 4.48            Location of the Assets
                  *   Schedule 4.49        Bank Accounts
                  Schedule 4.50            Powers of Attorney
                  Schedule 4.53            Trials
                  Schedule 7.6             Investment Letter
                  Schedule 7.7             Opinion of Vendors' Counsel
                  Schedule 7.13            Employment Contract
                  Schedule 7.18            Form of Resignation and Release of
                                           Directors and Officers of the Company
                  Schedule 7.21            Employees' Covenants

*  Confidential Treatment Requested for Portions of these Schedules

CE Electronic copy of certain Schedules to Exhibit 10.13 previously filed in
   paper pursuant to a temporary hardship exemption